Artivion | CRY - Cash And Equivalent

Stock Price
22.77
Daily Change
-0.16 -0.70%
Monthly
-38.02%
Yearly
-22.84%
Q2 Forecast
24.88

Artivion reported $55.76M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Abbott USD 6.8B 1.72B Mar/2026
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 55.76M 9.14M Mar/2026
AtriCure USD 146.16M 21.26M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
Inogen USD 106.48M 2.79M Sep/2025
Integra LifeSciences USD 236.81M 1.76M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 120.28M 38.25M Mar/2026
Pfizer USD 1.7B 561M Mar/2026
ResMed USD 1.66B 243.44M Mar/2026
Stryker USD 2.88B 1.13B Mar/2026
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 179.32M 88.69M Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Terumo JPY 217.16B 12.86B Sep/2025
Trinity Biotech USD 1.34M 3.83M Sep/2025